Apexigen, Inc. Operating Expenses
Apexigen, Inc. reported Operating Expenses of $6.16 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-08-10
- Apexigen, Inc. operating expenses for the quarter ending 2023-06-30 was $6.16M, a 24.39% decline year-over-year.
- Apexigen, Inc. operating expenses for the quarter ending 2023-03-31 was $6.22M, a 31.65% decline year-over-year.
- Apexigen, Inc. operating expenses for the quarter ending 2022-12-31 was $6.65M, a 17.90% decline year-over-year.
- Apexigen, Inc. operating expenses for the quarter ending 2022-09-30 was $8.80M, a 20.40% increase year-over-year.
- Apexigen, Inc. operating expenses for fiscal 2022 was $32.69M, a 12.88% increase from fiscal 2021.
- Apexigen, Inc. operating expenses for fiscal 2021 was $28.96M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-06-30 | $6.16M 10-Q · filed 2023-08-10 | $12.37M 10-Q · filed 2023-08-10 | $19.02M derived: sum of 3 quarters · filed 2023-08-10 | $27.82M derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $6.22M 10-Q · filed 2023-05-15 | $12.87M derived: sum of 2 quarters · filed 2023-05-15 | $21.66M derived: sum of 3 quarters · filed 2023-05-15 | $29.81M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-12-31 | $6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $15.45M derived: sum of 2 quarters · filed 2023-02-22 | $23.59M derived: sum of 3 quarters · filed 2023-08-10 | $32.69M 10-K · filed 2023-02-22 |
| 2022-09-30 | $8.80M 10-Q · filed 2022-11-14 | $16.94M derived: sum of 2 quarters · filed 2023-08-10 | $26.04M 10-Q · filed 2022-11-14 | $34.14M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $8.14M 10-Q · filed 2023-08-10 | $17.24M 10-Q · filed 2023-08-10 | $25.34M derived: sum of 3 quarters · filed 2023-08-10 | $32.65M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $9.09M 10-Q · filed 2023-05-15 | $17.19M derived: sum of 2 quarters · filed 2023-05-15 | $24.50M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $15.41M derived: sum of 2 quarters · filed 2023-02-22 | $28.96M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $7.31M 10-Q · filed 2022-11-14 | $20.86M 10-Q · filed 2022-11-14 |